|
Core Support for Cancer Center
|
3P30CA013330-39S4
|
$3,757,417
|
$75,148
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S5
|
$249,999
|
$5,000
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S6
|
$249,999
|
$5,000
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S7
|
$75,000
|
$1,500
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
The transcriptional basis of tumor promotion
|
5R01CA104292-09
|
$354,879
|
$354,879
|
LOCKER, JOSEPH
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
EASTERN COOPERATIVE ONCOLOGY GROUP
|
5U10CA014958-38
|
$101,749
|
$2,035
|
Sparano, Joseph
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Prevention of EtOH-induced promotion of hepatocarcinogenesis by genistein/soy
|
1R21CA169389-01
|
$193,140
|
$193,140
|
Ronis, Martin
|
ARKANSAS CHILDREN'S HOSPITAL RES INST
|
|
Guideline-based surveillance and treatment of hepatocellular carcinoma
|
5R01CA160738-02
|
$324,738
|
$324,738
|
Davila, Jessica
|
BAYLOR COLLEGE OF MEDICINE
|
|
BRIT1, A NOVEL HEPATOCELLULAR CARCINOMA TUMOR SUPPRESSOR
|
5R21CA161513-02
|
$171,064
|
$171,064
|
LI, KAIYI
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S1
|
$41,433
|
$2,072
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S2
|
$75,000
|
$3,750
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-06
|
$2,934,758
|
$146,738
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Steroid Receptor Coactivator-2 as a key hepatic tumor suppressor and circadian me
|
1F31CA171350-01
|
$26,232
|
$26,232
|
STASHI, ERIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Regulation of cell growth by RNA binding proteins
|
5R01CA100070-10
|
$258,839
|
$258,839
|
TIMCHENKO, NIKOLAI
|
BAYLOR COLLEGE OF MEDICINE
|
|
Role of Age in Liver Cancer
|
5R01CA159942-02
|
$324,738
|
$324,738
|
TIMCHENKO, NIKOLAI
|
BAYLOR COLLEGE OF MEDICINE
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-14
|
$95,411
|
$1,908
|
BUBLEY, GLENN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Optimizing localized therapy for primary liver cancer: a clinical trial and model
|
5K23CA139005-04
|
$169,560
|
$169,560
|
Miksad, Rebecca
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Role of POZ-zinc finger proteins in tumorigenesis.
|
5R01CA102142-08
|
$330,937
|
$109,209
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Cancer and Leukemia Group B
|
3U10CA031946-31S1
|
$114,228
|
$2,285
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B CCOP Research Base
|
3U10CA037447-27S1
|
$405,901
|
$4,059
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B
|
5U10CA031946-31
|
$7,759,618
|
$155,192
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B CCOP Research Base
|
5U10CA037447-28
|
$2,286,202
|
$22,862
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Obesity increased cancer risk by NKT cell depletion (PQ1)
|
1R21CA170194-01
|
$227,371
|
$113,686
|
EXLEY, MARK
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
A New Method for Improved Targeting in Image-guided Abdominal Interventions
|
5R01CA138586-03
|
$359,276
|
$359,276
|
Hata, Nobuhiko
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-38
|
$354,850
|
$7,097
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-22S3
|
$4,849,180
|
$193,967
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-22S4
|
$74,396
|
$2,976
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Effective PET Imaging in Liver Cancer
|
5R01CA095307-08
|
$408,368
|
$408,368
|
Lee, Zhenghong
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Children's Oncology Group Chair's Grant
|
3U10CA098543-10S3
|
$176,626
|
$3,533
|
ADAMSON, PETER
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Children's Oncology Group Chair's Grant
|
7U10CA098543-10
|
$26,733,729
|
$534,675
|
ADAMSON, PETER
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Community Clinical Oncology Program Research Base
|
2U10CA095861-11
|
$1,608,610
|
$32,172
|
POLLOCK, BRAD
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Cancer Center Support Grant
|
3P30CA033572-29S1
|
$91,911
|
$1,838
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-29S2
|
$139,999
|
$2,800
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-29S3
|
$75,000
|
$1,500
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
5P30CA033572-29
|
$2,225,352
|
$44,507
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
INVESTIGATION OF THE ROLES OF NUCLEAR RECEPTOR FXR IN HEPATOCELLULAR
|
5R01CA139158-02
|
$344,450
|
$344,450
|
HUANG, WENDONG
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CpG methylation and mutation
|
5R01CA084469-13
|
$283,061
|
$42,459
|
Pfeifer, Gerd
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
In-situ Guidance for Ultrasound Needle-based Interventions
|
1R43CA168127-01A1
|
$148,338
|
$133,504
|
Stolka, Philipp
|
CLEAR GUIDE MEDICAL, LLC
|
|
Cold Spring Harbor Laboratory Cancer Research Center
|
2P01CA013106-41
|
$4,298,042
|
$214,902
|
HANNON, GREGORY
|
COLD SPRING HARBOR LABORATORY
|
|
Cold Spring Harbor Laboratory Cancer Research Center
|
3P01CA013106-41S1
|
$188,000
|
$9,400
|
Hannon, Gregory
|
COLD SPRING HARBOR LABORATORY
|
|
CSHL CANCER CENTER SUPPORT GRANT
|
5P30CA045508-25
|
$4,346,720
|
$86,934
|
STILLMAN, BRUCE
|
COLD SPRING HARBOR LABORATORY
|
|
Cancer Center Support Grant
|
3P30CA013696-39S1
|
$140,000
|
$1,400
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-39S2
|
$75,000
|
$750
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-39
|
$3,816,425
|
$38,164
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Quantitative Volume and Density Response Assessment: Sarcoma and HCC as a Model
|
5U01CA140207-02
|
$583,741
|
$291,871
|
Schwartz, Lawrence
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Aberrant DNA Methylation of MicroRNA Genes in Hepatocellular Carcinoma (HCC)
|
5R03CA156629-02
|
$80,000
|
$80,000
|
Shen, Jing
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Methylation and Hepatocellular Carcinoma Outcomes
|
5K23CA149084-02
|
$170,790
|
$170,790
|
Siegel, Abby
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Myofibroblasts in Gastrointestinal Cancers
|
5U54CA163111-02
|
$504,181
|
$352,927
|
Wang, Timothy
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
2P30CA006516-47
|
$11,164,583
|
$223,292
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S1
|
$56,572
|
$1,131
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
Total relevant funding to Liver Cancer for this search: $64,559,887
|